Liz Pellicano is professor of autism at University College London in the United Kingdom
Liz Pellicano
Director, Centre for Research in Autism and Education
University College London
From this contributor
We need better strategies to support autistic people as the COVID-19 crisis continues
Interviews with autistic people reveal that many miss their friends and opportunities for social connection, in stark contrast to orthodox views that they have little social motivation and prefer a life of self-isolation.
We need better strategies to support autistic people as the COVID-19 crisis continues
By
Liz Pellicano
8 September 2020 | 6 min read
General practitioners urgently need autism training
Many general practitioners in the United Kingdom do not receive autism training, and report having little confidence in caring for patients on the spectrum.
General practitioners urgently need autism training
By
Laura Crane, Liz Pellicano, The Conversation
17 May 2017 | 5 min read
Friendships pose unique challenges for women on the spectrum
Women with autism value friendships as much as their neurotypical peers do, but they often have difficulty forming and maintaining them.
Friendships pose unique challenges for women on the spectrum
By
Liz Pellicano, Felicity Sedgewick
16 May 2017 | 6 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read